Wednesday, 8 January 2020

Merck's Keytruda wins U.S. FDA approval for bladder cancer

The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc's Keytruda for the treatment of a type of bladder cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)